Patient characteristics
| . | Arm A (0-1 RF) . | Arm B (2 RF) . | Total . |
|---|---|---|---|
| Pretreatment | |||
| Patients | 56 | 41 | 97 |
| Age, y | 36.2 (18.7-64.3) | 33.1 (21.3-71.5) | 35.3 (18.7-71.5) |
| Female/male | 35/21 | 21/20 | 56/41 |
| > 5 cm | 15 | 17 | 32 |
| Previous RT | 15 | 11 | 26 |
| Relapse in RT field | 10 | 8 | 18 |
| Refractory | 16 | 25 | 41 |
| Relapse > 1 year | 19 | 2 | 21 |
| Relapse < 1 year | 21 | 14 | 35 |
| ENS | 5 | 32 | 37 |
| B symptoms | 0 | 11 | 11 |
| Pre-ASCT | |||
| FDG-PET negative | 47 | 29 | 76 |
| IFRT/TLI | 35 | 22 | 56 |
| CBV/IFRT | 7 | 2 | 9 |
| CBV | 8 | 12 | 20 |
| . | Arm A (0-1 RF) . | Arm B (2 RF) . | Total . |
|---|---|---|---|
| Pretreatment | |||
| Patients | 56 | 41 | 97 |
| Age, y | 36.2 (18.7-64.3) | 33.1 (21.3-71.5) | 35.3 (18.7-71.5) |
| Female/male | 35/21 | 21/20 | 56/41 |
| > 5 cm | 15 | 17 | 32 |
| Previous RT | 15 | 11 | 26 |
| Relapse in RT field | 10 | 8 | 18 |
| Refractory | 16 | 25 | 41 |
| Relapse > 1 year | 19 | 2 | 21 |
| Relapse < 1 year | 21 | 14 | 35 |
| ENS | 5 | 32 | 37 |
| B symptoms | 0 | 11 | 11 |
| Pre-ASCT | |||
| FDG-PET negative | 47 | 29 | 76 |
| IFRT/TLI | 35 | 22 | 56 |
| CBV/IFRT | 7 | 2 | 9 |
| CBV | 8 | 12 | 20 |